ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2024

Jun 20, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK: 0001281895
Period of Report: 2024-06-13

Reporting Person: Malik Fady Ibraham (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-06-13	Stock Option (Right to Buy)	$22.86	A	23944	Acquired	2034-06-13	Common Stock (23944)	Direct

Footnotes

F1: This option represents a right to purchase a total of 23,944 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2025.